Vitamin D status in longstanding type 1 diabetes and controls. Association with upper extremity impairments
Abstract
Background: Patients with type 1 diabetes have a high prevalence of upper extremity impairments (UEIs), such as frozen shoulder, carpal tunnel syndrome, and trigger finger. The UEIs are strongly associated with activity limitations and impaired quality of life. The etiology of the UEI is not clear. Vitamin D deficiency has been considered to play a role in the pathogenesis of type 1 diabetes and in the development of macro- and microvascular complications in diabetes.
Aim: To characterize vitamin D status in a large population of patients with type 1 diabetes, if vitamin D deficiency is associated with metabolic factors and possible association with UEI.
Material and methods: Patients who diagnosed before 35 years of age, whose diabetes duration >20 years, and who are not older than 65 years were invited to participate in this cross-sectional case-control, multicenter study. Controls matched for age and sex were obtained from the national population registry. Fasting blood samples were collected and stored at −80°C until analyzed regarding 25-hydroxy-vitamin D (25(OH)D3) by a liquid chromatographic-mass spectrometric method (LC-MS/MS).
Results: Vitamin D levels varied with season as expected in the northern hemisphere. The association between 25(OH)D3 and clinical variables was analyzed in a univariate general linear model, which indicated no difference in 25(OH)D3 in men with and without diabetes but higher values in women with diabetes. About 30% of both patients and controls had vitamin D deficiency (≤50 nmol/L). Analyzed by binary logistic regression UEIs was not associated with 25(OH)D3 levels. In both patients and controls, 25(OH)D3 was correlated to apolipoprotein A1 (r = 0.153; 0.220, P < 0.001).
Conclusion: In patients with type 1 diabetes and a duration of 20 years or more, vitamin D level is not lower than in nondiabetic controls and is not associated with UEIs.
Downloads
References
2. Norris JM, Lee HS, Frederiksen B, et al. Plasma 25-Hydroxyvitamin D concentration and risk of islet autoimmunity. Diabetes. 2018;67:146–154. (In eng). doi: 10.2337/db17-0802
3. Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013;45:217–26. (In eng). doi: 10.1007/s12016-013-8361-3
4. Pozzilli P, Manfrini S, Crino A, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005;37:680–3. (In eng). doi: 10.1055/s-2005-870578
5. Littorin B, Blom P, Scholin A, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2006;49:2847–52. (In eng). doi: 10.1007/s00125-006-0426-x
6. Thorsen SU, Mortensen HB, Carstensen B, et al. No difference in vitamin D levels between children newly diagnosed with type 1 diabetes and their healthy siblings: a 13-year nationwide Danish study. Diabetes Care. 2013;36:e157–8. (In eng). doi: 10.2337/dc13-0342
7. Shen L, Zhuang QS, Ji HF. Assessment of vitamin D levels in type 1 and type 2 diabetes patients: results from metaanalysis. Mol Nutr Food Res. 2016;60:1059–67. (In eng). doi: 10.1002/mnfr.201500937
8. Herrmann M, Sullivan DR, Veillard AS, et al. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care. 2015;38:521–8. (In eng). doi: 10.2337/dc14-0180
9. Dibaba DT. Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis. Nutr Rev. 2019;77:890–902. (In eng). doi: 10.1093/nutrit/nuz037
10. Larkin ME, Barnie A, Braffett BH, et al. Musculoskeletal complications in type 1 diabetes. Diabetes Care. 2014;37:1863–9. (In eng). doi: 10.2337/dc13-2361
11. Gutefeldt K, Hedman CA, Thyberg ISM, Bachrach-Lindstrom M, Arnqvist HJ, Spangeus A. Upper extremity impairments in type 1 diabetes with long duration; common problems with great impact on daily life. Disabil Rehabil. 2017;41:1–8. (In eng). doi: 10.1080/09638288.2017.1397202
12. Gutefeldt K, Hedman CA, Thyberg ISM, Bachrach-Lindström M, Arnqvist HJ, Spångeus A. Low health-related quality of life is strongly linked to upper extremity impairments in type 1 diabetes with a long duration. Disabil Rehabil. 2021;43:2578–2584. (In eng). doi: 10.1080/09638288.2019.1705924
13. Gutefeldt K, Hedman CA, Thyberg ISM, Bachrach-Lindstrom M, Spangeus A, Arnqvist HJ. Dysregulated growth hormone-insulin-like growth factor-1 axis in adult type 1 diabetes with long duration. Clin Endocrinol (Oxf). 2018;89:424–430. doi: 10.1111/cen.13810
14. Turpeinen U, Hohenthal U, Stenman UH. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem. 2003;49: 1521–4. (In eng). doi: 10.1373/49.9.1521
15. Burdette CQ, Camara JE, Nalin F, et al. Establishing an accuracy basis for the Vitamin D External Quality Assessment Scheme (DEQAS). J AOAC Int. 2017;100:1277–1287. (In eng). doi: 10.5740/jaoacint.17-0306
16. Hill TR, McCarthy D, Jakobsen J, Lamberg-Allardt C, Kiely M, Cashman KD. Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women. Int J Vitam Nutr Res. 2007;77:320–5. (In eng). doi: 10.1024/0300-9831.77.5.320
17. Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care. 2009;32:1977–9. (In eng). doi: 10.2337/dc09-1089
18. Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18: 153–165. doi: 10.1007/s11154-017-9424-1
19. Eckel RH, Albers JJ, Cheung MC, Wahl PW, Lindgren FT, Bierman EL. High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes. 1981;30:132–8. (In eng). doi: 10.2337/diab.30.2.132
20. Taskinen MR, Kahri J, Koivisto V, Shepherd J, Packard CJ. Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:347–56. (In eng). doi: 10.1007/bf00401202
21. Vladimirova-Kitova LG, Deneva TI, Marinov B. Effect of moderate and high-dose simvastatin on asymmetric dimethylarginine-homocysteine metabolic pathways in patients with newly detected severe hypercholesterolemia. Cardiovasc Ther. 2011;29:340–8. (In eng). doi: 10.1111/j.1755-5922.2010.00149.x
22. Hallström S, Wijkman MO, Ludvigsson J, et al. Risk factors, mortality trends and cardiovasuclar diseases in people with Type 1 diabetes and controls: a Swedish observational cohort study. Lancet Reg Health Eur. 2022;21:100469. (In eng). doi: 10.1016/j.lanepe.2022.100469
23. Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb. 1992;12:671–4. (In eng). doi: 10.1161/01.atv.12.6.671
24. Heravifard S, Neyestani TR, Nikooyeh B, et al. Regular consumption of both vitamin D- and calcium- and vitamin D-fortified yogurt drink is equally accompanied by lowered blood lipoprotein (a) and elevated apoprotein A1 in subjects with type 2 diabetes: a randomized clinical trial. J Am Coll Nutr. 2013;32:26–30. (In eng). doi: 10.1080/07315724.2013.767659
25. John WG, Noonan K, Mannan N, Boucher BJ. Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. Am J Clin Nutr. 2005;82:517–22. (In eng). doi: 10.1093/ajcn.82.3.517
26. Rydberg M, Zimmerman M, Gottsäter A, Svensson AM, Eeg-Olofsson K, Dahlin LB. Diabetic hand: prevalence and incidence of diabetic hand problems using data from 1.1 million inhabitants in southern Sweden. BMJ Open Diabetes Res Care. 2022;10:1–9. (In eng) doi: 10.1136/bmjdrc-2021-002614
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to Upsala Medical Society. Read the full Copyright- and Licensing Statement.
